NASDAQ: CRSP · Biotechnology
Over the past week, CRISPR Therapeutics (CRSP) racked up about 48 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 51% bullish but is deeply split: News runs 69% bullish while Reddit sits at just 21%. Wall Street is more constructive, with 13 of 22 analysts rating CRSP a buy.
There is little buzz around CRSP this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 59% buy share sits next to a crowd that ranges from Reddit at 21% to News at 69%. No other tracker puts the two side by side.
Across 22 analysts the consensus is a Buy: 13 buy calls against 0 sell, with an average 12-month price target of $87.56.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 8 points above the crowd average of 51%, the professionals are more constructive than retail. The split is inside the crowd: News reads 69% bullish while Reddit sits at 21%, a 48-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, CRISPR Therapeutics (CRSP) buzz held subdued around 25.7 while the price drifted down 4.2% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.4M shares. Over the last 7 trading days, CRSP lost 9.1%. Buzz activity in the recent week averaged 35.1 and was variable, swinging between 20.5 and 49.1. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 16 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for CRSP and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CRSP sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 13, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Buy (13 / 9 / 0) |
| Crowd bullish (7d) | 51% |
| Avg price target | $87.56 |
| Most bullish source | News, 69% |
| Most bearish source | Reddit, 21% |
| Sentiment spread | 48 pts |
| Mentions (7d) | 48 |
| Market cap | $5.05B |
| P/E · Forward P/E | n/a · 23.4 |
| EPS · Beta | -$4.60 · 1.8 |
| Revenue (TTM) | $13.4M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, CRISPR Therapeutics (CRSP) currently carries an Adanos hold signal with 56/100 conviction. The current cross-source average reads 51% bullish across 3 active sources. Those sources contribute 48 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around CRISPR Therapeutics (CRSP) is fairly quiet with 14 mentions over the last 7 days; the 30-day context spans 12 tracked subreddits. The 7-day tone is 21% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads split on CRISPR Therapeutics (CRSP), averaging 51% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 69% bullish and Reddit at 21%, a 48-point spread. On the professional side, 13 of 22 analysts rate CRSP a buy.
Of the 22 analysts covering CRISPR Therapeutics (CRSP), 13 rate it a buy, 9 a hold and 0 a sell, for a buy consensus. The average price target is $87.56. That puts the street ahead of the crowd, which averages 51% bullish.
CRISPR Therapeutics (CRSP)'s cross-source average is mixed at 51% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. X reads 62% bullish, News reads 69% bullish and reddit coverage is the most negative at 21% bullish. The combined signal points to broad mixed pressure with 56/100 conviction.
The cross-source average is mixed for CRISPR Therapeutics (CRSP) at 51% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is reddit at 21% bullish. 3-day activity momentum is falling on X, while reddit and news activity is rising. The hold signal carries 56/100 conviction.
X is the dominant discussion channel with 21 mentions (44% of total volume). Reddit contributes 14 mentions and News contributes 13 mentions. The cross-source average is mixed at 51% bullish, while reddit and news show rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CRSP's hold signal at 56/100 conviction reflects a mixed cross-source average at 51% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The CRSP sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key